<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab2">
 <label>Table 2</label>
 <caption>
  <p>Infectious complications after haplo-PBSCT-Cord</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th/>
    <th>
     <italic>N</italic> (%)
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>CMV viremia</td>
    <td>12 (37.5%)</td>
   </tr>
   <tr>
    <td>CMV disease</td>
    <td>1 (3.1%)</td>
   </tr>
   <tr>
    <td>EB infection viremia</td>
    <td>13 (40.6%)</td>
   </tr>
   <tr>
    <td>PTLD EB related</td>
    <td>1 (3.4%)</td>
   </tr>
   <tr>
    <td>Hemorrhagic cystitis BK virus-related</td>
    <td>5 (15.6%)</td>
   </tr>
   <tr>
    <td>Pneumonia</td>
    <td/>
   </tr>
   <tr>
    <td>  Virus</td>
    <td>1 (3.1%)</td>
   </tr>
   <tr>
    <td>  Fungal</td>
    <td>3 (9.4%)</td>
   </tr>
   <tr>
    <td>  Bacteria</td>
    <td>1 (3.1%)</td>
   </tr>
   <tr>
    <td>Pneumocystis carinii pneumonia</td>
    <td>1 (3.1%)</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <italic>CMV</italic> cytomegalovirus, 
   <italic>PTLD</italic> posttransplant lymphoproliferative disorder
  </p>
 </table-wrap-foot>
</table-wrap>
